Q3 Newsletter

VGV Highlights: All VGV portfolio companies made or
exceeded their Q3 revenue targets

S4 Medical Meets Primary Endpoint in Esophagus Deviation During Radiofrequency Ablation of Atrial Fibrillation (EASY AF Study)

In an announcement from S4 Medical Corp, the company has announced that it is halting its EASY AF study due to successful achievement of its primary endpoint. After review of the data, the Data Safety and Monitoring Board advised to stop the study, as the study data demonstrates a statistically significant reduction in thermal injury to the esophagus during atrial fibrillation catheter ablation procedures.

The EASY AF Study was conducted under an investigational device exemption (IDE) approved by the U.S. Food and Drug Administration. The study treated 120 patients at 11 study centers in the USA and one in Argentina.

For more information, visit www.S4medical.com or follow S4 Medical on LinkedIn  and Twitter for more company updates.

Read more

Ohio to Receive Funding to Support Small Businesses

COLUMBUS, Ohio – The Ohio Department of Development today announced that up to $182 million will soon be available to support small businesses in Ohio.
 
“There is no better place to live, work, and raise a family than in Ohio, and our small businesses are a major reason why,” said Governor Mike DeWine. “My administration is dedicated to supporting the small businesses that are so integral to our state, especially those that need extra support to get off the ground and become a success.”

Read more

Industry News: How Low Could Valuations Go?

Enterprise-value-to-forward-revenue multiples are now below 2016 levels for the first time in 6 in years as the public software market continues to compress.

Read more